These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1422615)

  • 21. Postwithdrawal exposure treatment to prevent relapse in opiate addicts: a pilot study.
    Kasvikis Y; Bradley B; Powell J; Marks I; Gray JA
    Int J Addict; 1991 Nov; 26(11):1187-95. PubMed ID: 1683860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methadone maintenance and clonidine detoxification in the treatment of opiate addicts in Israel: suggesting evidence for cultural differences in the effectiveness of treatment modalities for opiate addiction.
    ShahamY ; Shufman ; Scher ; Barel ; Zlotogorski ; Cohen
    Isr J Psychiatry Relat Sci; 1991; 28(3):45-57. PubMed ID: 1666067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
    Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
    Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methadone dosages and therapeutic compliance during a methadone maintenance program.
    Maremmani I; Nardini R; Zolesi O; Castrogiovanni P
    Drug Alcohol Depend; 1994 Jan; 34(2):163-6. PubMed ID: 8026304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled use of heroin in patients on methadone maintenance treatment.
    Bianchi E; Maremmani I; Meloni D; Tagliamonte A
    J Subst Abuse Treat; 1992; 9(4):383-7. PubMed ID: 1479633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new approach to preventing relapse in opiate addicts: a psychometric evaluation.
    Grüsser SM; Thalemann CN; Platz W; Gölz J; Partecke G
    Biol Psychol; 2006 Mar; 71(3):231-5. PubMed ID: 16046046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rationale for maintenance pharmacotherapy of opiate dependence.
    Kreek MJ
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():205-30. PubMed ID: 1346939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outpatient opiate detoxification with clonidine.
    Washton AM; Resnick RB
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):39-41. PubMed ID: 7085584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of psychological factors on the opiate withdrawal syndrome.
    Phillips GT; Gossop M; Bradley B
    Br J Psychiatry; 1986 Aug; 149():235-8. PubMed ID: 3779283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) project: an open-label pragmatic randomised control trial comparing the efficacy of differing therapeutic agents for primary care detoxification from either street heroin or methadone [ISRCTN07752728].
    Oldham NS; Wright NM; Adams CE; Sheard L; Tompkins CN
    BMC Fam Pract; 2004 Apr; 5():9. PubMed ID: 15117415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical mismanagement in public methadone programs.
    Blansfield HN
    Conn Med; 1994 Mar; 58(3):161-4. PubMed ID: 8039380
    [No Abstract]   [Full Text] [Related]  

  • 33. The significance of alcoholism in treated opiate addicts.
    Rounsaville BJ; Weissman MM; Kleber HD
    J Nerv Ment Dis; 1982 Aug; 170(8):479-88. PubMed ID: 7097265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors predicting completion in a cohort of opiate users entering a detoxification programme.
    Mullen L; Keenan E; Barry J; Long J; Mulholland D; Grogan L; Delargy I
    Ir J Med Sci; 2010 Dec; 179(4):569-73. PubMed ID: 20174883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adolescents at risk: pain pills to heroin: part II.
    Fogger S; McGuinness TM
    J Psychosoc Nurs Ment Health Serv; 2015 Feb; 53(2):27-30. PubMed ID: 25654572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in heroin addicts seeking inpatient detoxification, ambulatory detoxification, or methadone maintenance.
    Steer RA
    Drug Alcohol Depend; 1979 Sep; 4(5):399-406. PubMed ID: 510180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonidine for opiate detoxification: outpatient clinical trials.
    Washton AM; Resnick RB
    Am J Psychiatry; 1980 Sep; 137(9):1121-2. PubMed ID: 7425173
    [No Abstract]   [Full Text] [Related]  

  • 38. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.
    Karow A; Reimer J; Schäfer I; Krausz M; Haasen C; Verthein U
    Drug Alcohol Depend; 2010 Dec; 112(3):209-15. PubMed ID: 20728288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personality measures in former heroin users receiving methadone or in protracted abstinence from opiates.
    Cohen LJ; Gertmenian-King E; Kunik L; Weaver C; London ED; Galynker I
    Acta Psychiatr Scand; 2005 Aug; 112(2):149-58. PubMed ID: 15992397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.